journal article·2023-01Open access

Cell penetrating peptide modified M2 macrophage derived exosomes treat spinal cord injury and rheumatoid arthritis by loading curcumin

Zhuo Li, Yajiang Yuan, Zhongming Zhang, Xiuming Zhang, Hui Yang, Huanan Li, Bao Han, Ziyang Deng, Zipeng Zhou, Xiangyi Fan

Materials & Design· Volume 225

Abstract

Effectively suppressing the hyperactivated inflammatory response is a critical strategy for treating inflammatory diseases, such as spinal cord injury (SCI) and rheumatoid arthritis (RA). Suitable anti-inflammatory drug delivery vehicles need to be continuously explored and discovered to achieve this goal. In this work, we designed M2 macrophage-derived engineered exosomes with a particle size of about 124 nm. Compared with untreated M2 macrophage-derived exosomes, cell-penetrating peptide modified primary M2 macrophage-derived exosomes can be better taken up by target cells, enabling inflammation targeting. The results of experiments in vivo also showed that after cell-penetrating peptide modification, the accumulation of exosomes at the site of inflammation was about 176% of that of unmodified ones. Experiments in SCI or RA mice also showed that primary M2 macrophage exosomes loaded with curcumin penetrating peptide modification had a more prominent ability to inhibit inflammation and improve motor function in inflammation models. Especially in promoting the repolarization of macrophages, in vitro experiments showed that under the action of curcumin loaded and R9 peptide modified M2 macrophage-derived exosomes (Cur@EXs-R9), more than 50% of macrophages were repolarized to M2-type macrophages. In conclusion, the engineered exosomes (Cur@EXs-R9) we designed, provides a new drug delivery carrier for treating inflammatory diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Autoimmune and Inflammatory Disorders Research · COVID-19 Impact on Reproduction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Mitochondrial control of inflammation, Nature reviews
2. Cascade of immune mechanism and consequences of inflammatory disorders10.1016/j.phymed.2021.153712 ↗
3. Nonresolving inflammation redux10.1016/j.immuni.2022.03.016 ↗
4. Immune response after central nervous system injury
5. Neurotransmitter phenotype switching by spinal excitatory interneurons regulates locomotor recovery after spinal cord injury10.1038/s41593-022-01067-9 ↗
6. Effects of Metabolic Disorders in Immune Cells and Synoviocytes on the Development of Rheumatoid Arthritis10.3390/metabo12070634 ↗
7. Molecular and cellular mechanisms of inflammation10.1134/S0006297916110018 ↗
8. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration10.1186/s12974-021-02337-2 ↗
9. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis10.1038/s41584-020-00541-7 ↗
10. Immune-mediated inflammatory disease therapeutics: past, present and future10.1038/s41577-021-00603-1 ↗
11. Gold nanoclusters for optimizing the general efficacies of herbal medicines on nerve repair after spinal cord injury10.1016/j.matdes.2022.110465 ↗
12. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury10.1038/s41467-022-28787-7 ↗
13. Electrospun strong, bioactive, and bioabsorbable silk fibroin/poly (L-lactic-acid) nanoyarns for constructing advanced nanotextile tissue scaffolds10.1016/j.mtbio.2022.100243 ↗
14. State-of-the-art review of advanced electrospun nanofiber yarn-based textiles for biomedical applications
15. Exosomes: cell-created drug delivery systems10.1007/s11010-019-03545-4 ↗
16. Exosome-eluting stents for vascular healing after ischaemic injury10.1038/s41551-021-00705-0 ↗
17. R. Kalluri, V. LeBleu, The biology function and biomedical applications of exosomes, Science (New York, N.Y.) 367(6478) (2020).10.1126/science.aau6977 ↗
18. Extracellular vesicles as a next-generation drug delivery platform10.1038/s41565-021-00931-2 ↗
19. Stimulation by Exosomes from Hypoxia Preconditioned Human Umbilical Vein Endothelial Cells Facilitates Mesenchymal Stem Cells Angiogenic Function for Spinal Cord Repair10.1021/acsnano.2c02898 ↗
20. Q. Meng, Y. Zhao, C. Dong, L. Liu, Y. Pan, J. Lai, Z. Liu, G. Yu, X. Chen, L. Rao, Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy, Angewandte Chemie (International ed. in English) 60(50) (2021) 26320-26326.10.1002/anie.202108342 ↗
21. Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells10.1038/s41551-021-00764-3 ↗
22. Q. Zhu, X. Ling, Y. Yang, J. Zhang, Q. Li, X. Niu, G. Hu, B. Chen, H. Li, Y. Wang, Z. Deng, Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy, Advanced science (Weinheim, Baden-Wurttemberg, Germany) 6(6) (2019) 1801899.10.1002/advs.201801899 ↗
23. Intranasal Delivery of Mesenchymal Stem Cell Derived Exosomes Loaded with Phosphatase and Tensin Homolog siRNA Repairs Complete Spinal Cord Injury10.1021/acsnano.9b01892 ↗
24. Diversity, Mechanisms, and Significance of Macrophage Plasticity10.1146/annurev-pathmechdis-012418-012718 ↗
25. Macrophage M1/M2 polarization
26. Z. Zhou, D. Li, X. Fan, Y. Yuan, H. Wang, D. Wang, X. Mei, Gold nanoclusters conjugated berberine reduce inflammation and alleviate neuronal apoptosis by mediating M2 polarization for spinal cord injury repair, Regenerative biomaterials 9 (2022) rbab072.10.1093/rb/rbab072 ↗
27. Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy10.1016/j.actbio.2021.03.018 ↗
28. Engineered extracellular vesicles derived from primary M2 macrophages with anti-inflammatory and neuroprotective properties for the treatment of spinal cord injury10.1186/s12951-021-01123-9 ↗
29. Engineering exosomes as refined biological nanoplatforms for drug delivery10.1038/aps.2017.12 ↗
30. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide10.1097/CAD.0b013e32835065ed ↗
31. The pharmacokinetics of cell-penetrating peptides10.1021/mp100223d ↗
32. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis10.1021/bi0612824 ↗
33. R. Kotha, D. Luthria, Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects, Molecules (Basel, Switzerland) 24(16) (2019).10.3390/molecules24162930 ↗
34. Y. Peng, M. Ao, B. Dong, Y. Jiang, L. Yu, Z. Chen, C. Hu, R. Xu, Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures, Drug design, development and therapy 15 (2021) 4503-4525.10.2147/DDDT.S327378 ↗
35. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-1310.1016/j.yjmcc.2015.04.025 ↗
36. M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds10.1016/j.intimp.2019.02.050 ↗
37. Effect of curcumin on the non-alcoholic steatohepatitis via inhibiting the M1 polarization of macrophages, Human & Experimental Toxicology 40(12_suppl) (2021) S310-S317.10.1177/09603271211038741 ↗
38. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies10.1016/j.biopha.2016.11.098 ↗
39. Points of control in inflammation10.1038/nature01320 ↗
40. Immunity, Inflammation, and Cancer10.1016/j.cell.2010.01.025 ↗
41. Inflammation and Cancer10.1016/B978-0-12-374279-7.17002-X ↗
42. Molecular inflammation: underpinnings of aging and age-related diseases10.1016/j.arr.2008.07.002 ↗
43. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment10.1038/embor.2012.142 ↗
44. Macrophage activation and its role in repair and pathology after spinal cord injury10.1016/j.brainres.2014.12.045 ↗
45. Traumatic spinal cord injury10.1038/nrdp.2017.18 ↗
46. Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents
47. Pathophysiology of Acute Spinal Cord Injury10.4184/jkss.2009.16.1.64 ↗
48. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis10.3390/cells9040880 ↗
49. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction10.1016/j.clim.2004.12.009 ↗
50. Molecularly Engineered Macrophage-Derived Exosomes with Inflammation Tropism and Intrinsic Heme Biosynthesis for Atherosclerosis Treatment10.1002/anie.201913700 ↗